Sinew Pharma, Inc.

As of June 30, 2026, Sinew Pharma, Inc. carries a market capitalization of 5.18B, placing it among publicly traded companies globally. Its enterprise value stands at 4.20B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Sinew Pharma, Inc. has 71.29M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Sinew Pharma, Inc. maintains a current ratio of 46.43, meaning it holds 46.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Sinew Pharma, Inc.'s stock has gained approximately 23.11% over the past 52 weeks. The 50-day moving average sits at 58.27, while the 200-day moving average is 50.91.

As of June 30, 2026, Sinew Pharma, Inc. holds 995.27M in cash and equivalents against 12.27M in total debt, resulting in a net debt position of -32.58M. Total book value stands at 1.04B, with working capital of 999.98M providing operational flexibility.

Sinew Pharma, Inc.'s most recent stock split took place on June 28, 2021 with a 636:655 split ratio.